Skip to main content
. 2019 Feb 16;45(6):1257–1266. doi: 10.1093/schbul/sby191

Fig. 5.

Fig. 5.

Validation of bioinformatic prediction of miRNA target genes. (A) Whole-blood BDNF mRNA levels between 45 FEDF SCZ patients and 45 controls. (B) Serum BDNF protein levels between 53 FEDF SCZ patients, 51 CT SCZ patients, and 47 controls. (C) KEGG pathway enrichment result for the SCZ-affected upregulated yellowgreen module. (D) GALNT8, (E) GLANT15, and (F) GLANT18 whole-blood mRNA levels between 45 FEDF SCZ patients and 45 controls. CT, chronically treated; FEDF, first-episode, drug-free. *P < .05, ***P < .001.